Literature DB >> 10586018

Endosonography in decision making and management of gastrointestinal endocrine tumors.

C De Angelis1, P Carucci, A Repici, M Rizzetto.   

Abstract

OBJECTIVE: gastroenteropancreatic (GEP) neuroendocrine tumors, suspected on clinical basis, are often difficult to localize. We report our experience with endoscopic ultrasonography (EUS) in the preoperative localization of pancreatic endocrine tumors (PETs), compared to other imaging modalities, and in staging and following up carcinoid tumors (CTs) of the gastrointestinal (GI) wall.
METHODS: 50 patients (20 males; mean age 54 years), 39 with suspected PETs and 11 with GI CTs underwent EUS (Olympus GF-UM2 or GF-UM3). EUS data could be compared with resected specimens in 25 out of the 39 PETs and five out of the 11 CTs.
RESULTS: in the PETs group 42 tumors (35<20 mm) were removed: 23 in the pancreas, eight in the duodenum, and 11 in the lymph nodes. EUS correctly localized 20 out of the 23 (87%) pancreatic tumors, included 11 out of the 12 (91.6%) insulinomas, three out of the eight (37.5%) duodenal gastrinomas, and ten out of the 11 (90.9%) metastatic lymph nodes. Furthermore EUS accurately evaluated the depth of parietal invasion of CTs in three out of four patients (75%) (two after and one prior to endoscopic resection). In three patients EUS was confirmed as normal on resected specimens (two pancreas and one stomach). In the PETs group, a correct localization was obtained by ultrasonography (US) only in 17.4% of cases, by computed tomography (CT) in 30.4%, by magnetic resonance imaging (MRI) in 25%, by angiography in 26.6%, and by somatostatin receptor scintigraphy in 15.4%.
CONCLUSION: EUS must be considered the first-intention method in localizing PETs and is helpful in decision making and management of GEP endocrine tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10586018     DOI: 10.1016/s0929-8266(99)00054-3

Source DB:  PubMed          Journal:  Eur J Ultrasound        ISSN: 0929-8266


  11 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 2.  Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysis.

Authors:  Srinivas R Puli; Nikhil Kalva; Matthew L Bechtold; Smitha R Pamulaparthy; Micheal D Cashman; Norman C Estes; Richard H Pearl; Fritz-Henry Volmar; Sonu Dillon; Michael F Shekleton; David Forcione
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 3.  [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].

Authors:  L Fischer; A Mehrabi; M W Büchler
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

4.  EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.

Authors:  Muslim Atiq; Manoop S Bhutani; Mehmet Bektas; Jeffrey E Lee; Yun Gong; Eric P Tamm; Chintan P Shah; William A Ross; James Yao; Gottumukkala S Raju; Xuemei Wang; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2011-10-01       Impact factor: 3.199

5.  Diagnostic accuracy of endoscopic ultrasonography for rectal neuroendocrine neoplasms.

Authors:  Hong-Tan Chen; Guo-Qiang Xu; Xiao-Dong Teng; Yi-Peng Chen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 6.  Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.

Authors:  Jeffrey A Norton; Robert T Jensen
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

7.  Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors.

Authors:  Yan Weng; Jingxue Ran; Yongmei Peng; Yining Xiang; Liangbi Xu
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 8.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.

Authors:  David C Metz; Robert T Jensen
Journal:  Gastroenterology       Date:  2008-08-12       Impact factor: 22.682

Review 9.  Management of neuroendocrine tumors of unknown primary.

Authors:  Krystallenia Alexandraki; Anna Angelousi; Georgios Boutzios; Georgios Kyriakopoulos; Dimitra Rontogianni; Gregory Kaltsas
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

10.  Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?

Authors:  Su Bum Park; Dong Jun Kim; Hyung Wook Kim; Cheol Woong Choi; Dae Hwan Kang; Su Jin Kim; Hyeong Seok Nam
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.